FierceBiotechOriginal article
{"a":[{"_":"Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact","$":{"href":"/biotech/flagships-profound-partners-gates-foundation-35m-preeclampsia-target-discovery-pact","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
Flagship Pioneering's ProFound Therapeutics partnered with the Gates Foundation in a deal worth up to $35 million to discover new drug targets for preeclampsia, a serious pregnancy complication.
Outcome Details
Target discovery collaboration for preeclampsia
Importance:6/10
Sentiment:
0.60
partnershipdrug discoverypreeclampsiaGates Foundationtarget identification
Related Companies
Read the original article
Published by FierceBiotech on August 26, 2026 4:48 PM